Try our Advanced Search for more refined results

Expert Analysis

Justices Struggle With BPCIA Enigma

By Tasha Francis and Jenny Shmuel, Fish & Richardson PC (April 27, 2017, 6:19 PM EDT) -- Oral arguments were heard on Wednesday in the landmark Amgen Inc. v. Sandoz Inc. case before the U.S. Supreme Court. This is the high court's first opportunity to weigh in on the Biologics Price Competition and Innovation Act, legislation creating an abbreviated regulatory pathway for biosimilars and a framework for resolving associated patent disputes. The case has garnered considerable public interest, with numerous amici briefs filed, including a brief filed by the United States....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!